Early Stages of Obesity-related Heart Failure Are Associated with Natriuretic Peptide Deficiency and an Overall Lack of Neurohormonal Activation: The Copenhagen Heart Failure Risk Study
References
- Poirier
P,
Giles
TD,
Bray
GA,
Hong
Y,
Stern
JS,
Pi-Sunyer
FX, et al. Obesity
and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of
Weight Loss: An Update of the 1997 American Heart Association Scientific
Statement on Obesity and Heart Disease From the Obesity Committee of the
Council on Nutrition, Physical. Circulation
[Internet]. (6
Feb
2006); 113(6):
898–918.
http://circ.ahajournals.org/cgi/doi/10.1161/CIRCULATIONAHA.106.171016 (16 Apr 2018). DOI: 10.1161/CIRCULATIONAHA.106.171016 - Vasan RS, Xanthakis V, Lyass A, Andersson C, Tsao C, Cheng S, et al. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study. An Echocardiographic Study Over 3 Decades. JACC Cardiovasc Imaging. 2017; 118529: 1–10. DOI: 10.1016/j.jcmg.2017.08.007
- Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002; 347(5): 949–55. DOI: 10.1056/NEJMoa020245
- Bello
NA,
Cheng
S,
Claggett
B,
Shah
AM,
Ndumele
CE,
Roca
GQ, et al.
Association of weight and body composition on cardiac
structure and function in the ARIC study (Atherosclerosis Risk in
Communities). Circ Hear Fail [Internet].
2016; 9(8):
1–7.
http://circheartfailure.ahajournals.org/content/9/8/e002978%0AData . DOI: 10.1161/CIRCHEARTFAILURE.115.002978 - Turkbey
EB,
McClelland
RL,
Kronmal
RA,
Burke
GL,
Bild
DE,
Tracy
RP, et al. The
impact of obesity on left ventricular mass and geometry – The
Multi-Ethnic Study of Atherosclerosis (MESA). JACC
Cardiovasc Imaging [Internet]. (1
Feb
2010); 3(3):
266–74.
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.1991.03470020057032 (16 Apr 2018). DOI: 10.1016/j.jcmg.2009.10.012 - Savji N, Meijers WC, Bartz TM, Bhambhani V, Cushman M, Nayor M, et al. The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF. JACC Hear Fail. 2018; 6(8): 701–9. DOI: 10.1016/j.jchf.2018.05.018
- Alpert
MA,
Lavie
CJ,
Agrawal
H,
Aggarwal
KB,
Kumar
SA. Obesity and
heart failure: epidemiology, pathophysiology, clinical manifestations, and
management. Transl Res [Internet].
(18
Apr
2014); 1–12.
http://www.ncbi.nlm.nih.gov/pubmed/24814682 (20 Jun 2014). - Sletten AC, Peterson LR, Schaffer JE. Manifestations and mechanisms of myocardial lipotoxicity in obesity. J Intern Med. 2018; 1–14.
- Kosmala W, Sanders P, Marwick TH. Subclinical Myocardial Impairment in Metabolic Diseases. JACC Cardiovasc Imaging. 2017; 10(6): 692–703. DOI: 10.1016/j.jcmg.2017.04.001
- Packer
M.
Leptin-Aldosterone-Neprilysin Axis.
Circulation [Internet]. 2018;
137(15):
1614–31.
http://circ.ahajournals.org/lookup/doi/10.1161/CIRCULATIONAHA.117.032474 . DOI: 10.1161/CIRCULATIONAHA.117.032474 - Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: Results from the Breathing Not Properly Multinational Study Lori. Am Heart J. 2006; 151(5): 999–1005. DOI: 10.1016/j.ahj.2005.10.011
- Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, et al. N-terminal pro-brain natriuretic peptide and heart failure risk among individuals with and without obesity: The Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2016; 133(7): 631–8. DOI: 10.1161/CIRCULATIONAHA.115.017298
- Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: Results from the Dallas Heart Study. Circulation. 2005; 112(14): 2163–8. DOI: 10.1161/CIRCULATIONAHA.105.555573
- Carlsen CM, Bay M, Kirk V, Gøtze JP, Køber L, Nielsen OW. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: A 10-year analysis from the Copenhagen Hospital Heart Failure Study. Eur J Heart Fail. 2012; 14(3): 240–7. DOI: 10.1093/eurjhf/hfs003
- Wijk SS, Van Empel V, Davarzani N, Maeder MT, Handschin R, Pfisterer ME, et al. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction. Eur J Heart Fail. 2015; 17: 1006–14. DOI: 10.1002/ejhf.414
- Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction. Circulation. 2017; 136(1): 6–19. DOI: 10.1161/CIRCULATIONAHA.116.026807
- Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL, et al. Cardiac natriuretic peptides, obesity, and insulin resistance: Evidence from two community-based studies. J Clin Endocrinol Metab. 2011; 96(10): 3242–9. DOI: 10.1210/jc.2011-1182
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016; 37(27): 2129–2200. DOI: 10.1093/eurheartj/ehw128
- Gaborit FS, Kistorp C, Kümler T, Hassager C, Tønder N, Køber L, et al. Prevalence of early stages of heart failure in an elderly risk population: The Copenhagen Heart Failure Risk Study. Open Hear; 2018. DOI: 10.1136/openhrt-2018-000840
- McMurray
JJV,
Adamopoulos
S,
Anker
SD,
Auricchio
A,
Böhm
M,
Dickstein
K, et al. ESC
Guidelines for the diagnosis and treatment of acute and chronic heart
failure 2012: The Task Force for the Diagnosis and Treatment of Acute and
Chronic Heart Failure 2012 of the European Society of Cardiology. Developed
in collaboration with the Heart. Eur Heart
J [Internet]. (Jul
2012); 33(14):
1787–847.
http://www.ncbi.nlm.nih.gov/pubmed/22611136 (23 May 2014). - Yeo
K-TJ,
Wu
AHB,
Apple
FS,
Kroll
MH,
Christenson
RH,
Lewandrowski
KB, et al.
Multicenter evaluation of the Roche NT-proBNP assay and
comparison to the Biosite Triage BNP assay. Clin
Chim Acta [Internet]. (1
Dec
2003); 338(1–2):
107–15.
https://www.sciencedirect.com/science/article/pii/S0009898103004170?via%3Dihub (7 Feb 2018). DOI: 10.1016/j.cccn.2003.08.016 - Morgenthaler NG, Struck J, Thomas B, Bergmann A. Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human Plasma. Clin Chem. 2004; 50(1): 234–6. DOI: 10.1373/clinchem.2003.021204
- Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006; 52(1): 112–9. DOI: 10.1373/clinchem.2005.060038
- Caruhel
P,
Mazier
C,
Kunde
J,
Morgenthaler
NG,
Darbouret
B. Homogeneous
time-resolved fluoroimmunoassay for the measurement of midregional
proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S
KRYPTOR®. Clin Biochem [Internet].
(1
May
2009) [cited 2018 Feb 6];
42(7–8):
725–8. Available from:
https://www.sciencedirect.com/science/article/pii/S0009912009000290?via%3Dihub (6 Feb 2018). DOI: 10.1016/j.clinbiochem.2009.01.002 - Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Hear J – Cardiovasc Imaging. 2015; 16: 233–71. DOI: 10.1093/ehjci/jev014
- Nagueh
SF,
Smiseth
OA,
Appleton
CP,
Byrd
BF,
Dokainish
H,
Edvardsen
T, et al.
Recommendations for the Evaluation of Left Ventricular
Diastolic Function by Echocardiography: An Update from the American Society
of Echocardiography and the European Association of Cardiovascular
Imaging. Eur Hear J – Cardiovasc
Imaging [Internet]. 2016;
17(12):
1321–60.
https://academic.oup.com/ehjcimaging/article-lookup/doi/10.1093/ehjci/jew082 . DOI: 10.1093/ehjci/jew082 - Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA. LVM Assessed by Echocardiography and Cardiac Magnetic Resonance, Cardiovascular Outcomes, and Medical Practice. 2013; 5(8): 837–48. DOI: 10.1016/j.jcmg.2012.06.003
- Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PWF, et al. Impact of Obesity on Plasma Natriuretic Peptide Levels. Circulation. 2004; 109(5): 594–600. DOI: 10.1161/01.CIR.0000112582.16683.EA
- Sinning C, Ojeda F, Wild PS, Schnabel RB, Schwarzl M, Ohdah S, et al. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients. Clin Res Cardiol. 2017; 106(6): 401–10. DOI: 10.1007/s00392-016-1066-x
- Kistorp C, Bliddal H, Goetze JP, Christensen R, Faber J. Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity. BMC Obes. 2014; 1(1): 1–9. DOI: 10.1186/s40608-014-0024-2
- Vila G, Riedl M, Maier C, Struck J, Morgenthaler NG, Handisurya A, et al. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity. 2009; 17(6): 1184–8. DOI: 10.1038/oby.2009.22
- Fernandes-Silva MM, Shah AM, Claggett B, Cheng S, Tanaka H, Silvestre OM, et al. Adiposity, body composition and ventricular-arterial stiffness in the elderly: The Atherosclerosis Risk in Communities Study. Eur J Heart Fail. 2018; 1–11. DOI: 10.1002/ejhf.1188
- Reddy
YNV,
Olson
TP,
Obokata
M,
Melenovsky
V,
Borlaug
BA. Hemodynamic
Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart
Failure With Preserved Ejection Fraction. JACC Hear
Fail [Internet]. (23
May
2018); Available from:
https://www.sciencedirect.com/science/article/pii/S2213177918302038 (7 Jul 2018). - Abramowitz
MK,
Hall
CB,
Amodu
A,
Sharma
D,
Androga
L,
Hawkins
M. Muscle mass, BMI,
and mortality among adults in the United States: A population-based cohort
study. Gorlova
OY (ed.), PLoS One
[Internet]. (11
Apr
2018); 13(4):
e0194697 . Available from:https://dx.plos.org/10.1371/journal.pone.0194697 (10 Dec 2019). DOI: 10.1371/journal.pone.0194697 - Fradley MG, Larson MG, Cheng S, McCabe E, Conglianese E, Shah RV, et al. Reference Limits for N-terminal-pro-B-type Natriuretic Peptide in Healthy Individuals (From the Framingham Heart Study). Am J Cardiol. 2011; 108(9): 1341–5. DOI: 10.1016/j.amjcard.2011.06.057
DOI: https://doi.org/10.5334/gh.776 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 6, 2019
Accepted on: Feb 18, 2020
Published on: Mar 25, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Freja Stoltze Gaborit, Caroline Kistorp, Thomas Kümler, Christian Hassager, Niels Tønder, Kasper Iversen, Pia R. Kamstrup, Jens Faber, Lars Køber, Morten Schou, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.